Virginia Tech® home

Shenglin Mei, PhD

Assistant Professor, Fralin Biomedical Research Institute at VTC
  • Assistant Professor, Department of Biomedical Sciences and Pathobiology

PhD, Bioinformatics, 2017
Tongji University
Shanghai, China

Vistiting Scholar, 2013-2014
Harvard T.H. Chan School of Public Health
Boston, MA

BS, Statistics, 2012
Nanjing Agricultural University
Nanjing China

2024–present
Assistant Professor, Biomedical Sciences and Pathobiology at VMCVM
Assistant Professor, Fralin Biomedical Research Institute at VTC
Fralin Biomedical Research Institute of Virginia Tech
Washington, DC

2024–present
Affiliate Member
Cancer and Immunology Research Center
Children's National Hospital
Washington, DC

2023–2024
Instructor
Harvard Medical School
Massachusetts General Hospital
Boston, MA

2018–2023
Postdoctoral Fellow
Harvard Medical School
Massachusetts General Hospital
Boston, MA

  • Mei, S., Zhang, H., et al. Single cell and spatial transcriptomics reveal tumor associated macrophages mediate prostate cancer progression and metastasis. Molecular Cancer Research. 23 (7): 653–65 (2025) . https://doi.org/10.1158/1541-7786.mcr-24-0791.
  • Mei, S., Alchahin, A. M., Embaie, B. T. et al. Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature. JCI insight, 9(6), e173337 (2024). https://doi.org/10.1172/jci.insight.173337
  • Mei, S., Alchahin, A. M., Tsea, I. et al. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. Genome medicine, 16(1), 1 (2024). https://doi.org/10.1186/s13073-023-01272-6
  • Hirz, T., Mei, S., Sarkar, H. et al. Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses. Nat Commun 14, 663 (2023). https://doi.org/10.1038/s41467-023-36325-2
  • Alchahin, A.M., Mei, S., Tsea, I. et al. A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma. Nat Commun 13, 5747 (2022). https://doi.org/10.1038/s41467-022-33375-w

  • Young Investigator Award, Royalty Pharma-Prostate Cancer Foundation, (2023-2026)
  • Challenge Award, Michael & Lori Milken Family Foundation-Prostate Cancer Foundation (2022-2025)

Tags